For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially ...
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has received “study may proceed” clearance from the U.S. Food and Drug Administration to initiate ...
A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...
MedPage Today on MSN
Similar Prostate Cancer Drugs Show Different Results in Real-World Study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...
Hosted on MSN
Expert Q&A: The Link Between Fatigue and Advanced Prostate Cancer — Plus Tips to Manage It
Many people with prostate cancer experience fatigue as a symptom of the cancer and as a side effect of treatment. In fact, up to 90 percent of men with prostate cancer experience fatigue.
As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...
Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...
—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results